Catatonia and genetic variant in GABA receptor: A case report involving GABRB2

Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology

(2023) Jonathan P Rogers et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Lorazepam in catatonia – Past, present and future of a clinical success story

(2023) Dusan Hirjak et al.   SCHIZOPHRENIA RESEARCH

Rethinking Catatonia: New Insights from the Autism Spectrum

(2022) Liliana Dell ’Osso et al.   CNS & Neurological Disorders-Drug Targets

Efficacity of tDCS in catatonic patients with Phelan McDermid syndrome, a case series

(2022) Mylène Moyal et al.   Brain Stimulation

Antipsychotic-induced catatonia and neuroleptic malignant syndrome: the dark side of the moon

(2021) Dusan Hirjak et al.   MOLECULAR PSYCHIATRY

Psychiatric illness and regression in individuals with Phelan-McDermid syndrome

(2020) Teresa M. Kohlenberg et al.   Journal of Neurodevelopmental Disorders

Neuropsychiatric expression and catatonia in 22q11.2 deletion syndrome: An overview and case series

(2018) Nancy J. Butcher et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART A

Catatonia in Children and Adolescents: A High Rate of Genetic Conditions

(2018) Marie Raffin et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Catatonia in children and adolescents: New perspectives

(2017) Xavier Benarous et al.   SCHIZOPHRENIA RESEARCH

Shank3 Deficiency Induces NMDA Receptor Hypofunction via an Actin-Dependent Mechanism

(2013) L. J. Duffney et al.   JOURNAL OF NEUROSCIENCE

Catatonia and Autism

(2009) Dirk M. Dhossche et al.   JOURNAL OF ECT